Stanniocalcin (STC) is a large polypeptide hormone that is widely distributed in tissues such as kidney, adrenal, and ovary. In most tissues, STC exists as a 50-kDa homodimer (STC 50 ). The ovaries produce a higher molecular weight variant (big STC) in androgen-producing theca cell and interstitial cell compartments. Luteal cells, which do not express the STC gene, nonetheless contain high levels of STC protein, suggesting they are targeted by and sequester big STC through a receptor-mediated process. Recently, an STCâ
alkaline phosphatase fusion protein was used to characterize mitochondrial targeting and sequestration of STC 50 and its receptor in liver and kidney. The main objective of the present study was to characterize big STC and its receptor in mammalian ovary and determine whether the ovarian STC variant was similarly targeted to luteal cell mitochondria. By in situ ligand binding, we identified large numbers of STC receptors on corpus luteal cells. However, a more detailed analysis of sub-cellular fractions revealed that both STC and its receptor were not preferentially targeted to mitochondria but instead to cholesterol/lipid storage droplets, which was more indicative of a role in steroidogenesis. Functional studies revealed that additions of big STC had concentration-dependent inhibitory effects on both basal and stimulated progesterone output by primary cultured luteal cells. Furthermore, STC receptor levels were upregulated in luteal cells in response to protein kinase A activation. Taken together, these findings indicate that theca cell-derived big STC is targeted to the cholesterol/ lipid storage droplets of luteal cells to regulate steroidogenesis. This constitutes the first reported description of polypeptide hormone and receptor targeting to cholesterol/lipid droplets and the first biological role for the big STC variant.The hormone stanniocalcin (STC) 1 is widely distributed in mammalian tissues and for the most part functions locally, because STC is not normally found in the blood. In most tissues, STC exists as a 50-kDa homodimer known as STC 50 . This form of the hormone has a unique signaling pathway whereby it is heavily sequestered by its target cells. In liver and kidney, for instance, STC 50 is first sequestered by target cells and then traffics to their mitochondria where it increases the rate of electron transport. Because STC receptors are present on both the plasma membranes and the mitochondria of target cells, the whole process appears to be receptor-mediated.By far the highest levels of STC gene expression are observed in the ovary (1), where the transcript is confined to theca and interstitial cells (TIC). Interestingly, STC protein is found not only in TICs but also in oocytes and cells of the corpus luteum (1), suggesting that the STC is produced by TICs for targeting to oocytes and luteal cells. The fact that the protein is readily detectable in cells that do not make the hormone further suggests that, as in the case of STC 50 signaling in liver and kidney (2), ovarian STC...